Go Your Own Way: Vector Laboratories Completes $124 Million Buyout and Initiates Acquisition Strategy

The new funding, backed by private equity firm Thompson Street Capital Partners, enables Vector Laboratories to embark upon an acquisition strategy while accelerating the commercialization of innovative labeling and detection technologies for immunohistochemistry, immunofluorescence, glycobiology, and bioconjugation. Through the buyout, Vector Laboratories reasons, it has gained the flexibility of a well-funded startup combined with a market-tested product portfolio driving innovative research by academic, industrial, and clinical researchers worldwide . . .

The post Go Your Own Way: Vector Laboratories Completes $124 Million Buyout and Initiates Acquisition Strategy appeared first on GEN – Genetic Engineering and Biotechnology News.

Source